Perceived high risk of COVID-19 vaccination: The revealing power of placebo

Michiel Beyens; Alessandro Toscano; Pierre Van Damme; Jean Michel Dogné; Didier G. Ebo; Vito Sabato

doi:10.1016/j.jaip.2023.03.031

Perceived high risk of COVID-19 vaccination: The revealing power of placebo

Michiel Beyens, Alessandro Toscano, Pierre Van Damme, Jean Michel Dogné, Didier G. Ebo, Vito Sabato

Research output: Contribution to journal › Article › peer-review

1 Downloads (Pure)

Abstract

The use of a placebo as an additional diagnostic step in the allergological workup of suspected hypersensitivity reactions can be of great value. In this study, nearly 1 in 3 patients had symptoms after administration of placebo.

Original language	English
Pages (from-to)	1954-1956
Number of pages	3
Journal	Journal of Allergy and Clinical Immunology: In Practice
Volume	11
Issue number	6
DOIs	https://doi.org/10.1016/j.jaip.2023.03.031
Publication status	Published - Jun 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jaip.2023.03.031

PIIS2213219823003185Final published version, 152 KBLicence: CC BY

Cite this

@article{1a003b34c20e40ee9ef2f8c7252eb1d8,

title = "Perceived high risk of COVID-19 vaccination: The revealing power of placebo",

abstract = "The use of a placebo as an additional diagnostic step in the allergological workup of suspected hypersensitivity reactions can be of great value. In this study, nearly 1 in 3 patients had symptoms after administration of placebo.",

author = "Michiel Beyens and Alessandro Toscano and {Van Damme}, Pierre and Dogn{\'e}, {Jean Michel} and Ebo, {Didier G.} and Vito Sabato",

year = "2023",

month = jun,

doi = "10.1016/j.jaip.2023.03.031",

language = "English",

volume = "11",

pages = "1954--1956",

journal = "Journal of Allergy and Clinical Immunology: In Practice",

issn = "2213-2198",

publisher = "Elsevier",

number = "6",

}

TY - JOUR

T1 - Perceived high risk of COVID-19 vaccination

T2 - The revealing power of placebo

AU - Beyens, Michiel

AU - Toscano, Alessandro

AU - Van Damme, Pierre

AU - Dogné, Jean Michel

AU - Ebo, Didier G.

AU - Sabato, Vito

PY - 2023/6

Y1 - 2023/6

N2 - The use of a placebo as an additional diagnostic step in the allergological workup of suspected hypersensitivity reactions can be of great value. In this study, nearly 1 in 3 patients had symptoms after administration of placebo.

AB - The use of a placebo as an additional diagnostic step in the allergological workup of suspected hypersensitivity reactions can be of great value. In this study, nearly 1 in 3 patients had symptoms after administration of placebo.

UR - http://www.scopus.com/inward/record.url?scp=85151844420&partnerID=8YFLogxK

U2 - 10.1016/j.jaip.2023.03.031

DO - 10.1016/j.jaip.2023.03.031

M3 - Article

C2 - 36965707

AN - SCOPUS:85151844420

SN - 2213-2198

VL - 11

SP - 1954

EP - 1956

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

IS - 6

ER -

Perceived high risk of COVID-19 vaccination: The revealing power of placebo

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this